PANELISTS: Darlene Solomon: Director of the Life Science Technologies Laboratory, Agilent Technologies
Jose B. Cibelli, D.V.M., Ph.D.: Vice-President of Research, A.C.T. Group
Benjamin Cravatt: Sripps Research Institute
David Sabatini: Whitehead Institute for Biomedical Research
ABOUT THE PANEL DISCUSSION: We've deciphered the human genome and moved into proteomics-the study of the individual proteins that the genes code for. Such advances anticipate the day when drugs are not only targeted at molecular workings or specific diseases but tailor-made for each individual's genetic makeup.
